Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$79.4M
5M shares
52-week range
$10.13 – $17.00
98% from low
Sector
SAVINGS INSTITUTION, FEDERALLY CHARTERED
Exchange
NASDAQ
CS
Borrow rate
0.36%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.7M | $16.8M | $17.7M | $17.5M | $17.3M | $18.4M | $26.7M | $28.7M |
| Cost of revenue | $3.1M | $3.9M | $3.7M | $1.4M | $1.7M | $9.3M | $13.5M | $13.3M |
| Gross profit | $12.5M | $12.9M | $14.0M | $16.1M | $15.6M | $9.1M | $13.2M | $15.4M |
| Gross margin | 79.9% | 76.6% | 79.3% | 91.8% | 89.9% | 49.6% | 49.6% | 53.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.3M | −$268.0K | $1.1M | $3.2M | −$1.0M | −$6.7M | $14.0K | −$1.5M |
| EBITDA | $1.9M | $260.0K | $1.6M | $3.8M | −$494.0K | −$6.2M | $398.0K | −$1.2M |
| Net income | $1.1M | −$79.0K | $1.1M | $2.6M | −$565.0K | −$10.7M | −$513.0K | −$845.0K |
| Net margin | 6.9% | -0.5% | 6.1% | 14.9% | -3.3% | -57.9% | -1.9% | -2.9% |
| EPS (diluted) | 0.40 | -0.03 | 0.18 | 0.45 | -0.12 | -2.29 | -0.12 | -0.23 |
Annual figures · source: Financial Modeling Prep
First Seacoast Bancorp Inc is the savings and loan holding company. The banks business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one- to four-family residential real estate loans, commercial real estate and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. It operates in single segment of Banking Services.
www.firstseacoastbank.comNo one on the platform currently holds FSEA.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 21,632 | $271.7K |
No one on the platform has traded FSEA yet.
| $64M |
| — |
| NSTSNSTS Bancorp, Inc. | $13.78 | +0.00% | $73M | — |
| OPHCOptimumBank Holdings, Inc. | $5.85 | +0.86% | $72M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 3.0× sales vs its 2.1× historical median P/S.
Fair value ≈ $11.68 · price $16.89 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Top Gainers PT2 $MASK.X $STRL $ONEG $FSEA $AIOS
View on StockTwits ↗$FSEA Cambridge Financial Group, Inc. and First Seacoast Bancorp, Inc. Agree to Merge https://marketwirenews.com/stock/fsea/news/cambridge-financial-group-inc-and-first-seacoast-ban-6971999877257629.html?utm_source=stocktwits
View on StockTwits ↗Stock - New 52 week high: $STRL $FSEA DOCN $EWTX $CYTK $FATE and so on...
View on StockTwits ↗Top Gainers PT2 $SOBR $FSEA $BIYA $STRL $BRCC
View on StockTwits ↗Morning Top Gainers PT2 $FSEA $EVER $VRDN $MASK.X $DGXX
View on StockTwits ↗$FSEA https://chrisdemuthjr.substack.com/p/brass-tacks-613
View on StockTwits ↗Pre Market Top Gainers $SDOT $DGXX $CLRB $FSEA $BLZE
View on StockTwits ↗Premarket Gainers: $SDOT $BLZE $CLRB $FSEA $DGXX Download this screener: https://stockanalysis.com/markets/premarket/gainers/?ref=saveontrading
View on StockTwits ↗Movers: $FSEA up 60% First Seacoast Bank To Be Acquired By Cambridge Financial Group At $17.25 Per Share In Cash In ~$80.9M Transaction $DGXX up 45% Digi Power X Executes Master Services Agreement With Cerebras For Colocation Of 40 MW AI Data Center Campus In Columbiana, AL; Initial 10-Yr Term Is Valued At ~$1.1B, With Total Potential Contract Value Of Up To $2.5B Inclusive Of Renewal Terms $VRDN up 34% Viridian Therapeutics Elegrobart Achieves 50-54% Proptosis And 61% Diplopia Responder Rates In Phase 3 REVEAL-2, Becoming Only Subcutaneous Program With Two Positive TED Pivotal Trials Viridian Therapeutics Q1 EPS $(0.90) Beats $(1.05) Estimate, Sales $141.000K Beat $27.500K Estimate
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.